Andrew Reardon
CLO & Secretary
Common Stock
- Value context
- $17.77K
- Reported price
- $52.27 / share
LIGAND PHARMACEUTICALS INC
Last 30 daysNo qualifying insider buying. Sales: $3.29M by 2 insiders.
Showing the first 6 of 20 trades on this page.
CLO & Secretary
Common Stock
CLO & Secretary
Common Stock
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
CLO & Secretary
Common Stock
CLO & Secretary
Common Stock
CLO & Secretary
Common Stock
CLO & Secretary
Common Stock
CLO & Secretary
Common Stock
CLO & Secretary
Employee Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Common Stock
Director
Common Stock
CLO & Secretary
Common Stock
CLO & Secretary
Common Stock
CLO & Secretary
Common Stock
CLO & Secretary
Common Stock
CLO & Secretary
Common Stock
Chief Financial Officer
Common Stock
Chief Financial Officer
Common Stock
Chief Financial Officer
Common Stock
Chief Financial Officer
Common Stock
Chief Financial Officer
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| CLO & Secretary | Common StockOption exercise or conversion10b5-1 | 340$52.27 / share | $17.77K | Oct 2Filed Oct 6 · 4d later | SEC filing |
| CLO & Secretary | Common StockSale10b5-16 trades | 5,000avg $304.07 / share | $1.52M | Oct 2Filed Oct 6 · 4d later | 6 filings
|
| CLO & Secretary | Employee Stock Option (right to buy)Option exercise or conversion10b5-1 | Derivative units340$52.27 exercise / conversion price | Not a separate purchase | Oct 2Filed Oct 6 · 4d later | SEC filing |
| Director | Common StockExercise-price or tax withholding | 115$298.50 / share | $34.33K | Sep 22Filed Sep 24 · 2d later | SEC filing |
| Director | Common StockSale | 1,200$285.00 / share | $342K | Sep 10Filed Sep 14 · 4d later | SEC filing |
| CLO & Secretary | Common StockSale10b5-15 trades | 5,000avg $286.09 / share | $1.43M | Sep 3Filed Sep 8 · 5d later | 5 filings
|
| Chief Financial Officer | Common StockOption exercise or conversion10b5-1 | 16,179$52.84 / share | $854.9K | Aug 12Filed Aug 14 · 2d later | SEC filing |
| Chief Financial Officer | Common StockOption exercise or conversion10b5-1 | 2,074$70.04 / share | $145.26K | Aug 12Filed Aug 14 · 2d later | SEC filing |
| Chief Financial Officer | Common StockOption exercise or conversion10b5-1 | 2,869$55.75 / share | $159.95K | Aug 12Filed Aug 14 · 2d later | SEC filing |
| Chief Financial Officer | Common StockOption exercise or conversion10b5-1 | 7,171$57.22 / share | $410.32K | Aug 12Filed Aug 14 · 2d later | SEC filing |
| Chief Financial Officer | Common StockOption exercise or conversion10b5-1 | 3,348$68.74 / share | $230.14K | Aug 12Filed Aug 14 · 2d later | SEC filing |
Showing the latest 20 of 139 trades. Show all 139 trades
Ligand Pharmaceuticals Incorporated - Common Stock (LGND) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberLigand Pharmaceuticals Incorporated - Common Stock (LGND) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberLigand Pharmaceuticals Incorporated - Common Stock (LGND) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberLigand Pharmaceuticals Incorporated - Common Stock (LGND) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House member